Can we predict the risk factors for switching due to ineffectiveness in the first year of therapy with bDMARD in patients with rheumatoid arthritis? Ana Martins; Sofia Pimenta; Daniela Oliveira; Rafaela Nicolau; Alexandra Bernardo; Teresa Martins Rocha; Lúcia Costa; Miguel Bernardes;

Impact of the COVID-19 pandemic on psychosocial health in rheumatic patients: A longitudinal study Laura Cano-García; Sara Manrique-Arija; Rocío Redondo-Rodríguez; Marta Vera-Ruiz; Jose Manuel Lisbona-Montañez; Arkaitz Mucientes-Ruiz; Aimara García-Studer; Fernando Ortiz-Marquez; Natalia Mena-Vázquez; Antonio Fernández-Nebro;

Comentario a: Realidad de la Reumatología en España y sus comunidades autónomas antes de la pandemia Dolors Grados Cànovas; Melania Martínez-Morillo; Alejandro Olivé Marqués;